Invex Therapeutics Ltd (ASX:IXC)

Invex Therapeutics Statistics

Total Valuation

ASX:IXC has a market cap or net worth of AUD 12.02 million. The enterprise value is 6.65 million.

Market Cap	12.02M
Enterprise Value	6.65M

Important Dates

The next estimated earnings date is Sunday, October 26, 2025.

Earnings Date	Oct 26, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:IXC has 75.15 million shares outstanding. The number of shares has increased by 0.51% in one year.

Current Share Class	75.15M
Shares Outstanding	75.15M
Shares Change (YoY)	+0.51%
Shares Change (QoQ)	-0.44%
Owned by Insiders (%)	28.01%
Owned by Institutions (%)	21.05%
Float	45.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	52.49
PB Ratio	2.29
P/TBV Ratio	2.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.94
EV / Sales	29.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 24.79

Current Ratio	24.79
Quick Ratio	24.79
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -8.72% and return on invested capital (ROIC) is -8.11%.

Return on Equity (ROE)	-8.72%
Return on Assets (ROA)	-7.65%
Return on Invested Capital (ROIC)	-8.11%
Return on Capital Employed (ROCE)	-13.52%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +113.33% in the last 52 weeks. The beta is 0.06, so ASX:IXC's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	+113.33%
50-Day Moving Average	0.10
200-Day Moving Average	0.08
Relative Strength Index (RSI)	75.92
Average Volume (20 Days)	59,111

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:IXC had revenue of AUD 229,084 and -476,868 in losses. Loss per share was -0.01.

Revenue	229,084
Gross Profit	229,084
Operating Income	-709,305
Pretax Income	-476,868
Net Income	-476,868
EBITDA	n/a
EBIT	-709,305
Loss Per Share	-0.01

Balance Sheet

The company has 5.38 million in cash and n/a in debt, giving a net cash position of 5.38 million or 0.07 per share.

Cash & Cash Equivalents	5.38M
Total Debt	n/a
Net Cash	5.38M
Net Cash Per Share	0.07
Equity (Book Value)	5.25M
Book Value Per Share	0.07
Working Capital	5.25M

Cash Flow

Operating Cash Flow	-652,572
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -309.63% and -208.16%.

Gross Margin	100.00%
Operating Margin	-309.63%
Pretax Margin	-208.16%
Profit Margin	-208.16%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:IXC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.51%
Shareholder Yield	n/a
Earnings Yield	-3.97%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:IXC has an Altman Z-Score of 11.19 and a Piotroski F-Score of 1.

Altman Z-Score	11.19
Piotroski F-Score	1